IVL 3004
Alternative Names: IVL-3004Latest Information Update: 20 Feb 2023
At a glance
- Originator Inventage Lab
- Class Drug withdrawal therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Alcoholism; Opioid-related disorders
Most Recent Events
- 23 Nov 2022 Preclinical trials in Alcoholism in South Korea (unspecified route) (Prior to November 2022)
- 23 Nov 2022 Preclinical trials in Opioid-related disorders in South Korea (unspecified route) (Prior to November 2022)
- 17 Nov 2022 Inventage Lab plans a phase I safety and pharmacokinetics trial in Healthy volunteers (IM, SC) (NCT05620940; IVL3004-001)